San Carlos, CA, United States of America

Xiaoju Ma

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents. Top assignee: Roche Sequencing Solutions, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoju Ma. Retrieved from https://idiyas.com/inventor/xiaoju-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Xiaoju Ma

Introduction

Xiaoju Ma is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of cancer therapy through his innovative methods. His work focuses on improving patient outcomes by utilizing advanced genetic analysis techniques.

Latest Patents

Xiaoju Ma holds a patent for a method of predicting response to therapy by assessing tumor genetic heterogeneity. This invention involves serial sampling of a patient's cell-free tumor nucleic acids to determine changes in the number of mutations per amount of plasma. This groundbreaking approach aims to enhance the precision of cancer treatment.

Career Highlights

Xiaoju Ma is currently employed at Roche Sequencing Solutions, Inc., where he continues to develop innovative solutions in the field of genomics. His expertise in genetic analysis has positioned him as a key player in advancing cancer therapy methodologies.

Collaborations

Xiaoju has collaborated with several professionals in his field, including Birgit Wehnl and Christine Ju. Their combined efforts contribute to the ongoing research and development of effective cancer treatment strategies.

Conclusion

Xiaoju Ma's contributions to cancer therapy through his innovative patent demonstrate the importance of genetic research in improving patient care. His work at Roche Sequencing Solutions, Inc. continues to pave the way for advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…